Drugmakers Accused of Causing Opioid Addiction in Trial

lawyer for several large California communities accused four drugmakers of causing a deadly wave of opioid addiction with their aggressive marketing of pain pills, while defense attorneys said the firms followed the law, on the opening day of a trial closely watched by the pharmaceutical industry.

“Without an avalanche of prescription opioids, there wouldn’t be an opioid epidemic,” said Fidelma Fitzpatrick, a plaintiffs’ lawyer hired to represent the counties of Los Angeles, Orange and Santa Clara and the city of Oakland.

The monthslong trial, being held fully by videoconference and decided solely by a judge, began Monday with opening remarks from Ms. Fitzpatrick and attorneys for the drugmakers being accused of misconduct— Johnson & Johnson, JNJ +0.71% Teva Pharmaceutical Ltd. TEVA -1.28% , Endo International ENDP -2.27% PLC and AbbVie Inc.’s Allergan.

The drugmakers argued Monday that they properly marketed their drugs under regulatory oversight and that the plaintiffs won’t be able to show examples of local deaths that stemmed from their prescriptions.

To Read This Article Please Click

Related Articles

Get Your Free Case Review Today

Cases are now under review, but there is a limited window to pursue help. If you think you, a friend, or a family member may qualify, get your free case review today before it’s too late.
Fields marked with an asterisk (*) are required.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Periscope Group logo (small)